Skip to content

Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment

Johannes Thrul, Albert Garcia‐romeu

Drugs Education Prevention and Policy April 30, 2021 DOI: 10.1080/09687637.2021.1897331 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Psilocybin
Keywords Hallucinogen Mental health Clinical psychology Psychotherapist
Citations 78
Key findings Research on therapeutic applications of Schedule I hallucinogens like psilocybin and MDMA is growing despite legal restrictions.

Abstract

Growing research on potential therapeutic applications of highly restricted Schedule I hallucinogens, including the ‘classic psychedelic’ psilocybin, and the entactogen 3,4-Methylenedioxymethamphet...

Explore topics